Glomerular Hyperfiltration and Renal Progression in Children with Autosomal Dominant Polycystic Kidney Disease

被引:62
|
作者
Helal, Imed [1 ]
Reed, Berenice [1 ]
McFann, Kim [1 ]
Yan, Xiang-Dong [1 ]
Fick-Brosnahan, Godela M. [1 ]
Cadnapaphornchai, Melissa [1 ]
Schrier, Robert W. [1 ]
机构
[1] Univ Colorado Denver, Div Renal Dis & Hypertens, Aurora, CO 80045 USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2011年 / 6卷 / 10期
关键词
VOLUME PROGRESSION; ADPKD; DIAGNOSIS; RISK; MICROALBUMINURIA; CREATININE; GROWTH; END;
D O I
10.2215/CJN.01010211
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives The purpose of this study was to determine whether glomerular hyperfiltration (GH) occurring early in autosomal dominant polycystic kidney disease (ADPKD) is indicative of more rapid disease progression in children. Design, setting, participants, & measurements One hundred eighty children with ADPKD (ages 4 to 18 years) with normal renal function were examined by renal ultrasound. Renal volume was calculated using a standard formula for a modified ellipsoid. Creatinine clearance was calculated from serum creatinine and 24-hour urine creatinine. GH was defined as creatinine clearance >= 140 ml/min per 1.73 m(2). Results Thirty-two children had GH (mean age 11.4 +/- 3.6 years) and 148 had normal renal function (mean age 10.8 +/- 3.9 years). Patients with GH at baseline demonstrated an increased rate of total renal volume growth (beta: rate of change = +19.3 +/- 10.8 cm(3)/year) over 5 years compared with those without GH at baseline (beta = -4.3 +/- 7.7 cm(3)/year), P = 0.008. Those with GH at baseline experienced a faster decline in creatinine clearance in subsequent years (beta = 5.0 +/- 0.8 ml/min per 1.73 m(2) per year) compared with those without GH at baseline (beta = +1.0 +/- 0.4 ml/min per 1.73 m(2) per year), P < 0.0001. Conclusions This study revealed that occurrence of CH in ADPKD children is associated with a significantly faster decline in renal function and higher rate of kidney enlargement over time. GH combined with the increased renal volume may therefore be used as an early marker for a more severe progression of ADPKD in children. J Am Soc Nephrol 6: 2439-2443, 2011. doi: 10.2215/CJN.01010211
引用
收藏
页码:2439 / 2443
页数:5
相关论文
共 50 条
  • [31] Urinary Biomarkers in Monitoring the Progression and Treatment of Autosomal Dominant Polycystic Kidney Disease-The Promised Land?
    Pana, Camelia
    Stanigut, Alina Mihaela
    Cimpineanu, Bogdan
    Alexandru, Andreea
    Salim, Camer
    Nicoara, Alina Doina
    Resit, Periha
    Tuta, Liliana Ana
    MEDICINA-LITHUANIA, 2023, 59 (05):
  • [32] Cystatin C estimated glomerular filtration rate to assess renal function in early stages of autosomal dominant polycystic kidney disease
    Sans, Laia
    Radosevic, Aleksandar
    Quintian, Claudia
    Montanes, Rosario
    Gracia, Silvia
    Vilaplana, Carles
    Mojal, Sergi
    Ballarin, Jose A.
    Fernandez-Llama, Patricia
    Torra, Roser
    Pascual, Julio
    PLOS ONE, 2017, 12 (03):
  • [33] Study of candidate genes affecting the progression of renal disease in autosomal dominant polycystic kidney disease type I
    Tazon-Vega, Barbara
    Vilardell, Mireia
    Perez-Oller, Laureano
    Ars, Elisabet
    Ruiz, Patricia
    Devuyst, Olivier
    Lens, Xose
    Fernandez-Llama, Patricia
    Ballarin, Jose
    Torra, Roser
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (06) : 1567 - 1577
  • [34] A Computable Phenotype for Autosomal Dominant Polycystic Kidney Disease
    Kalot, Mohamad A.
    El Alayli, Abdallah
    Al Khatib, Mohammad
    Husainat, Nedaa
    McGreal, Kerri
    Jalal, Diana, I
    Yu, Alan S. L.
    Mustafa, Reem A.
    KIDNEY360, 2021, 2 (11): : 1728 - 1733
  • [35] Pharmacologic Management of Autosomal Dominant Polycystic Kidney Disease
    Ackley, William
    Dahl, Neera K.
    Park, Meyeon
    ADVANCES IN KIDNEY DISEASE AND HEALTH, 2023, 30 (03): : 228 - 235
  • [36] Imaging for the prognosis of autosomal dominant polycystic kidney disease
    Bae, Kyongtae T.
    Grantham, Jared J.
    NATURE REVIEWS NEPHROLOGY, 2010, 6 (02) : 96 - 106
  • [37] Infectious complications in autosomal dominant polycystic kidney disease
    Pirson, Yves
    Kanaan, Nada
    NEPHROLOGIE & THERAPEUTIQUE, 2015, 11 (02): : 73 - 77
  • [38] Autosomal dominant polycystic kidney disease: updated perspectives
    Rastogi, Anjay
    Ameen, Khalid Mohammed
    Al-Baghdadi, Maha
    Shaffer, Kelly
    Nobakht, Niloofar
    Kamgar, Mohammad
    Lerma, Edgar, V
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2019, 15 : 1041 - 1052
  • [39] Outcome of renal replacement therapy in autosomal dominant polycystic kidney disease
    Pirson, Y
    Christophe, JL
    Goffin, E
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 : 24 - 28
  • [40] Assessing the Risk of Progression to Kidney Failure in Patients With Autosomal Dominant Polycystic Kidney Disease
    Lanktree, Matthew B.
    Kline, Timothy
    Pei, York
    ADVANCES IN KIDNEY DISEASE AND HEALTH, 2023, 30 (05): : 407 - 416